Cenni, V.; Bavelloni, A.; Capanni, C.; Mattioli, E.; Bortolozzo, F.; Kojic, S.; Orlandi, G.; Bertacchini, J.; Blalock, W.L.
ANKRD2 Knockdown as a Therapeutic Strategy in Osteosarcoma: Effects on Proliferation and Drug Response in U2OS and HOS Cells. Int. J. Mol. Sci. 2025, 26, 1736.
https://doi.org/10.3390/ijms26041736
AMA Style
Cenni V, Bavelloni A, Capanni C, Mattioli E, Bortolozzo F, Kojic S, Orlandi G, Bertacchini J, Blalock WL.
ANKRD2 Knockdown as a Therapeutic Strategy in Osteosarcoma: Effects on Proliferation and Drug Response in U2OS and HOS Cells. International Journal of Molecular Sciences. 2025; 26(4):1736.
https://doi.org/10.3390/ijms26041736
Chicago/Turabian Style
Cenni, Vittoria, Alberto Bavelloni, Cristina Capanni, Elisabetta Mattioli, Federico Bortolozzo, Snezana Kojic, Giulia Orlandi, Jessika Bertacchini, and William L. Blalock.
2025. "ANKRD2 Knockdown as a Therapeutic Strategy in Osteosarcoma: Effects on Proliferation and Drug Response in U2OS and HOS Cells" International Journal of Molecular Sciences 26, no. 4: 1736.
https://doi.org/10.3390/ijms26041736
APA Style
Cenni, V., Bavelloni, A., Capanni, C., Mattioli, E., Bortolozzo, F., Kojic, S., Orlandi, G., Bertacchini, J., & Blalock, W. L.
(2025). ANKRD2 Knockdown as a Therapeutic Strategy in Osteosarcoma: Effects on Proliferation and Drug Response in U2OS and HOS Cells. International Journal of Molecular Sciences, 26(4), 1736.
https://doi.org/10.3390/ijms26041736
